Product information
| Price | €175, €275, €395 |
|---|---|
| Size | 20 µl/µg | 50 µl/µg | 100 µl/µg |
| Short name | APRIL Antibody |
| Host | Rabbit |
| Isotype | IgG |
| Target protein | TNFSF13 |
| Recommended applications | ELISA, IF, IHC-p, WB |
| Reactivity | Human, Mouse, Rat |
| Immunogen | The antiserum was produced against synthesized peptide derived from human TALL-2. AA range:151-200 |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Formulation | Liquid in PBS containing 50% glycerol; 0.5% BSA and 0.02% sodium azide. |
| Storage | -20°C for 1 year |
| Product code | MB-AP11764 |
Additional information
Prev
Next
The protein encoded by TNFSF13 is a member of the tumor necrosis factor (TNF) ligand family. This protein (tumor necrosis factor superfamily member 13) is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Alternative splicing results in multiple transcript variants. Some transcripts that skip the last exon of the upstream gene (TNFSF12) and continue into the second exon of TNFSF13 have been identified; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13.
TNFSF13, APRIL, TALL2, ZTNF2, Tumor necrosis factor ligand superfamily member 13, A proliferation-inducing ligand, APRIL, TNF- and APOL-related leukocyte expressed ligand 2, TALL-2, TNF-related death
Human: O75888, Mouse: Q9D777
Human: 8741, Mouse: 69583
